NewsMV
Integra LifeSciences Holdings Corporation (NASDAQ: IART) has finalized the pricing for a $450,000,000 aggregate principal amount of 9.500% senior secured notes due 2033.
The company announced the terms on October 9, 2026, in Princeton, N.J., signaling the next phase of a broader refinancing strategy that aims to restructure its existing debt load.
The new notes will serve as general senior secured obligations of the company, backed by guarantees from wholly-owned domestic subsidiaries that act as guarantors under Integra's current senior secured credit facilities.
This structure ensures the debt is secured by the same corporate entities that support its existing borrowing arrangements.
Keep reading